Pancreatic Neuroendocrine Tumor
Last Posted: Jul 14, 2020
- Inherited syndromes involving pancreatic neuroendocrine tumors.
Geurts Jennifer L et al. Journal of gastrointestinal oncology 2020 Jun 11(3) 559-566
- Association between genetic polymorphisms in long non-coding RNAs and pancreatic cancer risk.
Moschovis D, et al. Cancer biomarkers : section A of Disease markers 2019 0 (1) 117-123
- Novel Mutations in Serbian MEN1 Patients: Genotype-phenotype Correlation.
Isailovic Tatjana, et al. Journal of medical biochemistry 2019 3 (1) 38-44
- Pilot study of rapid MR pancreas screening for patients with BRCA mutation.
Corrias Giuseppe et al. European radiology 2019 Jan
- Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panel.
Gleeson Ferga C, et al. Oncotarget 2017 11 (55) 93464-93475
- Genetic polymorphisms of interleukin 1ß gene and sporadic pancreatic neuroendocrine tumors susceptibility.
Karakaxas Dimitrios, et al. World journal of gastrointestinal oncology 2016 6 (6) 520-5
- The Clinical Utility of a Novel Blood-Based Multi-Transcriptome Assay for the Diagnosis of Neuroendocrine Tumors of the Gastrointestinal Tract.
Modlin I M et al. Am. J. Gastroenterol. 2015 Jun 2.
- KRAS and DAXX/ATRX gene mutations are correlated with the clinicopathological features, advanced diseases, and poor prognosis in Chinese patients with pancreatic neuroendocrine tumors.
Yuan Fei, et al. International journal of biological sciences 2014 0 (9) 957-65
- The FGFR4-G388R single-nucleotide polymorphism alters pancreatic neuroendocrine tumor progression and response to mTOR inhibition therapy.
Serra Stefano, et al. Cancer research 2012 11 (22) 5683-91
- Pancreatic neuroendocrine tumor
From NCATS Genetic and Rare Diseases Information Center
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.